Live Chart

O 3.85

H 3.85

L 3.85

VOL 3358

Welcure Drugs & Pharmaceuticals Overview

Days Range

Low: ₹3.85
High: ₹3.89
Previous Close ₹3.89
Open ₹3.85
Volume 16,752
Day’s Range ₹3.85 - ₹3.89
52W Range ₹3.31 - ₹10.95
Market Cap ₹5.26 Cr

Fundamentals of Welcure Drugs & Pharmaceuticals

ROCE (TTM) NA
P/E Ratio (TTM) NA
P/B Ratio NA
Industry P/E NA
Debt to Equity NA
ROE NA
EPS (TTM) NA
Dividend Yield NA
Book Value NA
Face Value NA

Financials of Welcure Drugs & Pharmaceuticals

Financials data is not available for Welcure Drugs & Pharmaceuticals. Please visit after some time.

About Welcure Drugs & Pharmaceuticals

Incorporated on 4 Jun.'92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceutical ... Read More

Parent Organisation Indian Private
Founded 1996
Managing Director NA
NSE Symbol NA

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,264.38

277.25

4.05 (-1.44%)

276 - 283.25
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹52.24

45.25

2.25 (-4.74%)

45.1 - 46.05
Procter & Gamble Health Ltd ₹8,177.41

4862.8

69.80 (-1.42%)

4851.5 - 4954.3
Veerhealth Care Ltd ₹41.24

26

0.00 (0.00)

26 - 26

What's Trending

FAQs

What is the Share price of Welcure Drugs & Pharmaceuticals ()?

Welcure Drugs & Pharmaceuticals () share price as of September 22, 2023, on BSE is Rs 3.89 (BSE).

Can I buy Welcure Drugs & Pharmaceuticals () shares?

Yes, You can buy Welcure Drugs & Pharmaceuticals () shares by opening a Demat account with Angel One.

How do I buy Welcure Drugs & Pharmaceuticals () from Angel One?

Welcure Drugs & Pharmaceuticals () share can be brought through the following modes:
  1. Direct investment: You can buy Welcure Drugs & Pharmaceuticals () shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Welcure Drugs & Pharmaceuticals () shares.